News From the USA 'Experimental drug slows kidney cancer'

Reuters10	Reuters10	Reuters10	Reuters10	Reuters10	Reuters10	Reuters10
Reuters10	Reuters10

One off donation
Regular donation

Kidney Cancer in the 2010 UK Election News >>

NICE reject Bevacizumab, sorafenib and temsirolimus >>

Press archive - 2009 >>

Press archive - 2010 >>

Press archive - 2008 >>

Press archive - 2007 >>

Press archive - 2006 >>

HEALTH MINISTER ORDERS CLINICAL AUDIT ON ACCESSING KIDNEY CANCER DRUG >>
24 December 2008

James Whale Talks To Mature Times >>
13 October 2008

Continuing the Fight >>
6 September 2008

NICE Demo >>
2 September 2008

James Whale on GMTV Talking about NICE >>
9 August 2008

Countrywide announce James Whale Fund for Kidney Cancer as Staff Charity >>
21 July 2008

Cyclists arrive at Journey's End >>
3 June 2008

James Whale Blog: May/ June 2008 >>
21 May 2008

Move to North could help cancer patient live - The Sunday Sun >>
20 May 2008

News From the USA 'Experimental drug slows kidney cancer' >>
20 May 2008

Salford PCT declined to pay for Sutent >>
20 May 2008

James Whale Blog - April 2008 >>
9 April 2008

NICE is recruiting new members to independent advisory committees on the use of health technologies. >>
3 March 2008

Comment From: James Whale >>
1 February 2008

Carol Vorderman supports UK Patient Survey >>
1 February 2008

20 May 2008

Reuters report from America that an experimental drug called RAD-001 or everolimus from Swiss drugmaker Novartis slowed the progression of kidney cancer in patients whose tumors returned after initial chemotherapy,